🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of participants share comparison images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, advertising, and customer regulations, risking fines, legal action or imprisonment.

Service Response and Material Elimination

Based on TikTok, the service has taken down problematic material and banned associated hashtags and search suggestions. The company said it was committed to maintaining the service secure and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, glowing reviews and detailed instructions for preparing or administering at home.

After moments of joining one group, a vendor shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Product Details and Pricing

Inside these communities, posts show dark colored parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has already encountered individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to potentially significant medical dangers”.